Therapeutic Drug Monitoring Cardioactive Drugs Drug Treatment For Therapeutic Level Toxic Level Toxic Effects Other Information Digoxin
Therapeutic Drug Monitoring Cardioactive Drugs Drug Treatment For Therapeutic Level Toxic Level Toxic Effects Other Information Digoxin
Cardioactive Drugs
Drug Treatment for Therapeutic Level Toxic level Toxic effects Other information
Digoxin Atrial arrhythmia and 0.5-2 ng/mL >2 ng/mL Nausea, vomiting, Therapeutic actions and
congenital heart visual disturbances, toxicities can be
failure premature ventricular influenced by serum
contractions and electrolytes
atrioventricular bode 25% of this is protein
blockage bound
Hyperthyroid individuals
are resistant to digoxin
Peak level: 8 hours after
oral dose
Half-life: 38 hours
Lidocaine Used to correct 1.5-4.0 ug/mL >4.0 ug/mL CHF and heart block Can be used as local
(Xylocaine) ventricular arrythmia anesthetic
for treatment of acute (1.5-1.0 sa handouts) CNS depression: It is bound to albumin
myocardial infarction >4-8 ug/mL and AAG
Primary product of
Seizure and decreased hepatic metabolism:
bp and cardiac output: monoethylglycinexylidide
>8 ug/mL (MEGX)
Quinidine For the treatment of 2.3-5.0 ug/mL >5ug/mL Cinchonism, blood 85% protein
arrythmia dyscrasia, and Peak serum level: 2 hours
hepatitis after an oral dose
(sulfate), 4-5 hours
(gluconate)
Procainamide To treat ventricular 4-10 ug/mL >12 ug/mL Reversible lupus-like 20% protein bound
(Pronestyl) arrythmia syndrome (ANA), Hepatic metabolite: N-
nephritic syndrome, acetyl procainamide
urticaria (NAPA)
REVIEWER FOR CLINICAL CHEMISTRY 2 - GDMDV 17
ANTIBIOTICS
Drug Treatment for Therapeutic Level Toxic level Toxic effects Other information
Aminoglycosides Treatment for Gram- Amikacin and Nephrotoxicity and Administered through
(Gentamicin, negative bacterial Kanamycin: ototoxicity IM or IV, not well-
Tobramycin, infections >30 ug/mL – peak absorbed from GIT.
Amikacin, level May cause damage to
Kanamycin, 8th cranial nerve
Neomycin, or Gentamicin and
Streptomycin) tobramycin:
12-15 ug/mL – peak
Vancomycin Effective against gram- 5-10 ug/mL – toxic Nephrotoxicity: “Red-man syndrome”, Trough levels are
positive cocci and side effects can occur >10 ug/mL nephrotoxicity, monitored to ensure
bacilli ototoxicity the serum drug
Ototoxicity: concentration is within
>40 ug/mL the therapeutic range
Chloramphenicol >25 ug/mL Blood dyscrasia, Distributed to all
cytoplasmic tissues, concentrates
vacuolation in the CSF.
REVIEWER FOR CLINICAL CHEMISTRY 2 - GDMDV 18
ANTIEPILEPTIC DRUGS
Drug Treatment for Therapeutic Level Toxic level Toxic effects Other information
Phenobarbital It is a long-acting Nystagmus, stupor, Not used for petit mal
barbiturate that ataxia, and respiratory seizure.
controls grand mal depression. Absorption is low but
tonic- clonic seizure complete.
and focal epileptic. 50% protein bound,
For treating stored in brain.
withdrawal symptoms Renal impairment
in infants-mothers are slows down
addicted to opiate or elimination process.
barbiturate. Inactive proform:
Used to treat cases of primidone (mysoine).
congenital Half-life: 70-100 hours.
hyperbilirubinemia Peak serum level:
Phenobarbital: 20-
40ug/mL
Primidone: 5-12
ug/mL
Phenytoin (Dilatin) It controls seizures 10-20 ug/mL >20 ug/mL Toxicity may be seen Not used for petit mal
(tonic-clonic, simple in therapeutic levels. and atomic seizures.
partial seizures) Free form: Major toxicity: Decreases sodium and
Short-term 1-2 ug/mL initiation of seizures; calcium influx into
prophylactic agent in teratogenic action hyperexcitable
brain injury. (cleft lip and palate) neurons.
and nystagmus IV administered, GIT
absorption incomplete.
87-97% protein bound
Free form: if
biologically active
portion.
Injectable proform:
fosphenytoin
REVIEWER FOR CLINICAL CHEMISTRY 2 - GDMDV 19
Valproic Acid Treatment for petit 50-100 ug/mL >100 ug/mL (NLW) >100 ug/mL: Orally administered,
(Depakene) mal (absence of Nausea, lethargy, and GIT is rapid and
seizure), atomic >200 ug/mL (PHH) weight gain complete.
seizure, and grand mal Highly protein bound
seizure >200 ug/mL: (93%).
Pancreatitis, Hepatic dysfunction
hallucinations, can be observed,
hyperammonemia monitoring requires
after 6 months of
therapy
Carbamazepine Effective for grand mal 4-16 ug/mL >12 ug/mL Idiosyncratic effects: Tricyclic compound
(Tegretol) seizures and treating Rashes, leukopenia, related to imipramine
seizures accompanied nausea, vertigo, febrile (TCA).
by pain. reactions. Not frequently used –
has serious toxic effect.
Toxic effects: Orally administered.
Hematologic
dyscrasias, aplastic
anemia, irregular pulse
and ataxia.
Ethosuximide Controlling petit mal 40-100 ug/mL >100 ug/mL Gi disturbances, ataxia, Orally administered.
(Zarontin) (absence) seizure SLE, aplastic anemia Free in serum and not
and pancytopenia protein bound.
Gabapentin Used for partial 2-15 ug/mL Adverse Effect: Chemically similar to
(Neurontin) seizures, adjunctive Dizziness, ataxia, neurotransmitter
therapy fatigue, and gamma aminobutyric
nystagmus. acid (GABA).
Administered orally,
Toxic effects: unbound to plasma
Ataxia and somnolence proteins.
Drug Treatment for Therapeutic Level Toxic level Toxic effects Other information
REVIEWER FOR CLINICAL CHEMISTRY 2 - GDMDV 20
Lithium Treatment for manic- 0.8-1.2 mmol/L 1.2-2 mmol/L (ALS) Severe dehydration, Inhibits thyroid
depressive illness >2 mmol/L (SMC) nephrotoxicity, and hormone synthesis
(bipolar disorder). hypothyroidism. and release.
Drug of choice for Inhibits iodine uptake.
prevention of chronic 1.2-2 mmol/L: A cationic metal.
cluster headache Apathy, lethargy, Orally administered
speech difficulties and absorption rapid
and complete.
>2 mmol/L: Lithium and
Seizures, muscle democlocycline inhibit
rigidity, and coma. the effect of ADH in the
kidney.
BRONCHODILATOR
Drug Treatment for Therapeutic Level Toxic level Toxic effects Other information
Theophylline Treatment for asthma 10-20 ug/mL >20 ug/mL GI bleeding, seizures, Inhibitory to the
and chronic tachycardia and release of histamine
obstructive pulmonary syncope. and other
disease. proinflammatory
Drug for primary agents.
apnea for prematurity 50% protein-bound
REVIEWER FOR CLINICAL CHEMISTRY 2 - GDMDV 21
– absence of Initially IV
respiratory effort in administered, then
newborn infants. orally.
Crosses placenta and
can be teratogenic to
pregnant women,
Best predictor of
toxicity is the blood
level of drug not the
signs and symptoms.
IMMUNOSUPPRESSIVE DRUGS
Drug Treatment for Therapeutic Level Toxic level Toxic effects Other information
Cyclosporine Used to prevent 300 ng/mL: >500 ng/mL Renal tubular, Marked affinity with
rejection of allogenic For heart, liver, and glomerular RBC.
organ transplant. pancreatic dysfunctions, GI Temperature
For suppression of disturbances, dependent.
acute graft-versus-host hirsutism, and Orally administered
disease (GVHD) hematologic dyscrasia with 5-50%
absorption
Specimen of choice:
whole blood.
ANTINEOPLASTIC DRUGS
Drug Treatment for Therapeutic Level Toxic level Toxic effects Other information
Methotrexate Effective therapy for a 0.01 umol/L Leukopenia, GI Inhibits DNA synthesis
variety of neoplastic ulceration, in all cells, by blocking
conditions. thrombocytopenia, dihydrofolate
Immunosuppressive cirrhosis reductase.
agent Leucovorin is used to
reverse the action of
methotrexate-
leucovorin rescue.
Busulfan Used to treat Overdose can cause Alkylating agent
leukemias and hepatic occlusive
lymphomas prior to disease
bone marrow
transplantation
ANTI-INFLAMMATORY/ANALGESICS
Drug Treatment for Therapeutic Level Toxic level Toxic effects Other information
Salicylates/Aspirin Commonly used Acute aspirin Direct stimulator of
(Acetylsalicylic Acid) analgesic, antipyretic intoxication-common respiratory system.
and anti-inflammatory cause of fatal drug Inhibitor of Krebs’
drug poisoning in children. Cycle.
Has anticoagulatory
Side effects: activity by inhibiting
GI disturbance, and the action of
interference with cyclooxygenase.
platelet aggregation. Decreases
thromboxane and
prostaglandin
Toxic effects: formation.
Mixed acid-base
disturbance,
hypoglycemia, and
Reye’s syndrome.
Acetaminophen Commonly used as 25 ug/mL >50 ug/mL Overdose of this drug Inhibitor of
(Tylenol) analgesic and may cause prostaglandin
antipyretic drug Hepatic necrosis: hepatotoxicity. metabolism.
100-300 ug/mL
REVIEWER FOR CLINICAL CHEMISTRY 2 - GDMDV 23
Toxic Effect:
Cyanosis due to
methemoglobinemia,
CNS depression and
seizure.
Ibuprofen Has analgesic and anti- 10-50 ug/mL >100 ug/mL Nausea, vomiting, Has lower risk of
inflammatory actions blurred vision, toxicities that
abdominal pain, salicylates and
edema acetaminophen
NEUROLEPTICS
Drug Treatment for Therapeutic Level Toxic level Toxic effects Other information
Antipsychotic Major Treatment for acute Cholestasis, orthostatic Blocks the action of
Tranquilizers schizophrenia hypotension, aplastic dopamine and
anemia, muscle serotonin in the limbic
rigidity. system.
Difficult to monitor in
serum due to
abundant metabolites.
Two classes:
Phenotiazines
(chlorpromazine) and
butyrophenones
(haloperidol)
TOXIC AGENTS
ALCOHOL
ALCOHOL
CARBON MONOXIDE
REVIEWER FOR CLINICAL CHEMISTRY 2 - GDMDV 25
Carbon Monoxide Characteristics Function Major Toxic Effects Toxic Level Laboratory
Colorless, odorless, Binds with heme Diminish available 20% CO Sample: EDTA whole
tasteless gas. proteins. oxygen to the tissue or blood.
Produced by Has higher affinity for tissue hypoxia due to Definitive method for
incomplete hemoglobin than does inhibition of the testing: cooximetry
combustion of carbon- oxygen. oxyhemoglobin (carboxyhemoglobin
containing substances. Stimulates production saturation measurement).
Indication of acute of nitrous oxide
toxicity: “Cherry red” resulting to Susceptible organs:
color of face hypotension of brain and heart.
neurologic changes.
CYANIDE
METALS
Mode of acquisition: or mimic that adrenal gland >50 ug/dL – whole blood
disorder.
Alkyl mercury:
Congenital minimata
disease
DRUGS OF ABUSE
Blood Alcohol Level Signs and Symptoms Strongly impaired motor skills
0.01-0.05 No obvious impairment Staggering/slurred speech
0.03-0.12 Mild euphoria 0.27-0.40 Unable to stand or walk
Low inhibitions Vomiting
Some impairment of motor skills. Impaired consciousness
0.09-0.25 Low inhibitions 0.36-0.50 Coma and possible death
Loss of critical judgement
Memory impairment
Diminished reaction time • Reg beer: 5%
0.18-0.30 Mental confusions • Malt liquor: 7%
Dizziness • Wine: 12%
REVIEWER FOR CLINICAL CHEMISTRY 2 - GDMDV 30
• Wine: 76 mL
• Beer: 250 mL
• Hard: 25 mL
• Alcopop/Cider: 275 mL
• **no more than 14 units/week
• **distributed in three days/week